Infused Total Nucleated Cell Dose is a Better Predictor of Transplant Outcomes Than CD34+ Cell Dose for Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Children

被引：0

作者：

Wells, Joseph Russell ^{[1
]}

Sunkara, Anusha ^{[2
]}

Kang, Guolian ^{[2
]}

Hale, Jennifer ^{[1
]}

Hughes, Carlton ^{[1
]}

Alloush, Lina ^{[1
]}

Madden, Renee ^{[1
]}

Qudeimat, Amr ^{[1
]}

Mamcarz, Ewelina ^{[1
]}

Leung, Wing H. ^{[1
]}

Janssen, William ^{[1
]}

Triplett, Brandon M. ^{[1
]}

Srinivasan, Ashok ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA

[2] St Jude Childrens Res Hosp, Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

582

引用

页码：S396 / S397

页数：2

共 50 条

[31] Impact of CD34+ cell dose on the outcome of patients undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT).
Diez-Campelo, M
Perez-Simon, JA
Martino, R
Canals, C
Caballero, D
Mateos, V
Sierra, J
San Miguel, JF
BLOOD, 2002, 100 (11) : 837A - 837A
[32] Higher Infused CD34+Cell Dose Does Not Influence Clinical Outcomes in Allogeneic Peripheral Blood Stem Cell Transplantation Using Post-Transplant Cyclophosphamide in Children with High-Risk Leukemia
Yoo, Jae Won
Jo, Suejung
Kim, Seongkoo
Lee, Jae Wook
Chung, Nack-Gyun
Jeong, Dae-Chul
Cho, Bin
BLOOD, 2023, 142
[33] Predictive value for engraftment and survival of total nucleated cell dose (TNC) as compared to CD34+ cell dose after autologous and allogeneic bone marrow transplant (BMT) for hematologic malignancies.
Kassim, AA
Mineishi, S
Jagasia, M
Vurisikala, M
Goodman, S
Greer, JP
Chinratanalab, W
Ruffner, K
Morgan, DS
Stein, RS
Brandt, S
Schuening, FG
BLOOD, 2004, 104 (11) : 346B - 346B
[34] CD34+Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
Elmariah, Hany
Naqvi, Syeda Mahrukh Hussnain
Kim, Jongphil
Nishihori, Taiga
Mishra, Asmita
Perez, Lia
Liu, Hien D.
Khimani, Farhad
Nieder, Michael
Pidala, Joseph
Bejanyan, Nelli
BLOOD, 2019, 134
[35] Impact of transplanted CD 34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation.
Sohn, SK
Kim, DH
Kim, JG
Suh, JS
Lee, KB
BLOOD, 2002, 100 (11) : 453B - 453B
[36] CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer
Baron, F
Copizza, S
Baudoux, E
Jerusalem, G
Fillet, G
Beguin, Y
HAEMATOLOGICA, 2004, 89 (09) : 1146 - 1148
[37] Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
JE Kiss
WB Rybka
A Winkelstein
M deMagalhaes-Silverman
J Lister
P D’Andrea
ED Ball
Bone Marrow Transplantation, 1997, 19 : 303 - 310
[38] Higher Total Nucleated Cell Dose, but Not CD3+, 4+, 8+, or 34+Cell Dose, Is Associated with Better Overall and Progression-Free Survival after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (AlloPBHCT) with TBI-Based Conditioning Regimens
Burns, Michael
Singh, Anurag
Zhang, Yali
Chen, George L.
Liu, Hong
Ross, Maureen
McCarthy, Philip L.
Hahn, Theresa
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S30 - S31
[39] Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity
Migliaccio, AR
Adamson, JW
Stevens, CE
Dobrila, NL
Carrier, CM
Rubinstein, P
BLOOD, 2000, 96 (08) : 2717 - 2722
[40] Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation
Knudsen, LM
Jensen, L
Jarlbæk, L
Hansen, PG
Hansen, SW
Drivsholm, L
Nikolaisen, K
Gaarsdal, E
Johnsen, HE
HAEMATOLOGICA, 1999, 84 (06) : 517 - 524

← 1 2 3 4 5 →